Fein Luis相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

A plain language summary of POLARIS: a study to look at different doses of encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis

POLARIS 研究简明摘要：一项旨在研究不同剂量恩考拉非尼联合比美替尼治疗 BRAF V600 突变型脑转移性黑色素瘤患者的研究

期刊:Future Oncology

影响因子:2.6

doi:10.1080/14796694.2025.2495540

Menzies, Alexander M; Long, Georgina V; Kohn, Amiee; Tawbi, Hussein; Webe, Jeffrey; Flaherty, Keith; McArthur, Grant A; Ascierto, Paolo A; Pfluger, Yanina; Lewis, Karl; Tsai, Katy K; Hamid, Omid; Prenen, Hans; Fein, Luis; Wang, Erjian; Guenzel, Carolin; Zhang, Fan; Kleh, Joseph F; di Pietro, Alessandra; Davies, Michael A

发表日期：2025

文献求助收藏

POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis

POLARIS：一项评估恩考拉非尼联合比美替尼治疗BRAF V600突变型脑转移黑色素瘤患者的高剂量和标准剂量方案的II期试验

期刊:NeuroOncology Advances

影响因子:4.1

doi:10.1093/noajnl/vdae033

Menzies, Alexander M; Long, Georgina V; Kohn, Amiee; Tawbi, Hussein; Weber, Jeffrey; Flaherty, Keith; McArthur, Grant A; Ascierto, Paolo A; Pfluger, Yanina; Lewis, Karl; Tsai, Katy K; Hamid, Omid; Prenen, Hans; Fein, Luis; Wang, Erjian; Guenzel, Carolin; Zhang, Fan; Kleha, Joseph F; di Pietro, Alessandra; Davies, Michael A

发表日期：2024

文献求助收藏

SGLT2 inhibition improves PI3KÎ± inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials.

SGLT2 抑制剂可改善 PI3Kα 抑制剂引起的血糖升高：来自临床前动物模型和 BYLieve 和 SOLAR-1 试验患者的研究结果

期刊:Breast Cancer Research and Treatment

doi:10.1007/s10549-024-07405-8

Borrego Manuel Ruiz, Lu Yen-Shen, Reyes-Cosmelli Felipe, Park Yeon Hee, Yamashita Toshinari, Chiu Joanne, Airoldi Mario, Turner Nicholas, Fein Luis, Ghaznawi Farhat, Singh Jyotika, Pantoja Kristyn, Schnell Christian, Akdere Murat, Chia Stephen

发表日期：2024

文献求助收藏

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

卡博替尼联合纳武利尤单抗和伊匹木单抗治疗肾细胞癌

期刊:New England Journal of Medicine

影响因子:78.5

doi:10.1056/NEJMoa2212851

Choueiri, Toni K; Powles, Thomas; Albiges, Laurence; Burotto, Mauricio; Szczylik, Cezary; Zurawski, Bogdan; Yanez Ruiz, Eduardo; Maruzzo, Marco; Suarez Zaizar, Alberto; Fein, Luis E; Schutz, Fabio A; Heng, Daniel Y C; Wang, Fong; Mataveli, Fabio; Chang, Yu-Lin; van Kooten Losio, Maximiliano; Suarez, Cristina; Motzer, Robert J

细胞生物学

发表日期：2023

文献求助收藏

Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer

一项开放标签、随机、多中心、III期研究，比较口服紫杉醇联合恩塞奎达与静脉注射紫杉醇治疗转移性乳腺癌患者的疗效

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.21.02953

Rugo, Hope S; Umanzor, Gerardo A; Barrios, Francisco J; Vasallo, Rosa H; Chivalan, Marco A; Bejarano, Suyapa; Ramírez, Julio R; Fein, Luis; Kowalyszyn, Ruben D; Kramer, E Douglas; Wang, Hui; Kwan, Min-Fun R; Cutler, David L

发表日期：2023

文献求助收藏

Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate

更正：一项针对拉丁美洲绝经后 HR+/HER2- 晚期乳腺癌女性患者的帕博西尼联合来曲唑治疗的扩大用药研究，这些患者被认为适合接受来曲唑治疗。

期刊:Clinical Drug Investigation

影响因子:2.7

doi:10.1007/s40261-023-01305-3

Fein, Luis; Lazaretti, Nicolas; Chuken, Yamil López; Benfield, J Rogelio González Ramírez; Mano, Max S; Lobaton, Jose; Korbenfeld, Ernesto; Damian, Fernanda; Lu, Dongrui R; Mori, Ave; Patyna, Shem J; Franco, Sandra

发表日期：2023

文献求助收藏

Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate

一项针对拉丁美洲绝经后HR+/HER2-晚期乳腺癌女性患者的帕博西尼联合来曲唑扩大用药研究，这些患者被认为适合接受来曲唑治疗。

期刊:Clinical Drug Investigation

影响因子:2.7

doi:10.1007/s40261-023-01294-3

Fein, Luis; Lazaretti, Nicolas; Chuken, Yamil López; Benfield, J Rogelio González Ramírez; Mano, Max S; Lobaton, Jose; Korbenfeld, Ernesto; Damian, Fernanda; Lu, Dongrui R; Mori, Ave; Patyna, Shem J; Franco, Sandra

发表日期：2023

文献求助收藏

Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study

生物类似药与原研药培非格司亭预防化疗引起的嗜中性粒细胞减少症的比较：一项 III 期随机、多中心、评估者盲法、非劣效性研究

期刊:JCO Global Oncology

doi:10.1200/GO.21.00276

Kowalyszyn, Ruben D; Fein, Luis E; Richardet, Martin E; Varela, Mirta S; Ortiz, Eduardo; Micheri, Cristian; Zarba, Juan J; Kahl, Susana; Klimovsky, Ezequiel; Federico, Andrea A; Cassini, Jorge H; Cortese, Gustavo; Lago, Nestor

细胞生物学

中性粒细胞

发表日期：2022

文献求助收藏